These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29450199)

  • 1. Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.
    Dreier J; Knabbe C; Vollmer T
    Front Med (Lausanne); 2018; 5():5. PubMed ID: 29450199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis E virus blood donor NAT screening: as much as possible or as much as needed?
    Vollmer T; Diekmann J; Knabbe C; Dreier J
    Transfusion; 2019 Feb; 59(2):612-622. PubMed ID: 30548866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of transfusion-transmitted hepatitis E virus infection from pool-tested platelets and plasma.
    Cordes AK; Goudeva L; Lütgehetmann M; Wenzel JJ; Behrendt P; Wedemeyer H; Heim A
    J Hepatol; 2022 Jan; 76(1):46-52. PubMed ID: 34461207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven years (2015-2021) of blood donor screening for HEV-RNA in France: lessons and perspectives.
    Laperche S; Maugard C; Lhomme S; Lecam S; Ricard C; Dupont I; Richard P; Tiberghien P; Abravanel F; Morel P; Izopet J; Gallian P
    Blood Transfus; 2023 Mar; 21(2):110-118. PubMed ID: 35969132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients.
    Westhölter D; Hiller J; Denzer U; Polywka S; Ayuk F; Rybczynski M; Horvatits T; Gundlach S; Blöcker J; Schulze Zur Wiesch J; Fischer N; Addo MM; Peine S; Göke B; Lohse AW; Lütgehetmann M; Pischke S
    J Hepatol; 2018 Jul; 69(1):36-42. PubMed ID: 29551705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.
    Ling AE; Robbins KE; Brown TM; Dunmire V; Thoe SY; Wong SY; Leo YS; Teo D; Gallarda J; Phelps B; Chamberland ME; Busch MP; Folks TM; Kalish ML
    JAMA; 2000 Jul; 284(2):210-4. PubMed ID: 10889595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors.
    Vollmer T; Knabbe C; Dreier J
    J Clin Microbiol; 2014 Jun; 52(6):2150-6. PubMed ID: 24740079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.
    Hewitt PE; Ijaz S; Brailsford SR; Brett R; Dicks S; Haywood B; Kennedy IT; Kitchen A; Patel P; Poh J; Russell K; Tettmar KI; Tossell J; Ushiro-Lumb I; Tedder RS
    Lancet; 2014 Nov; 384(9956):1766-73. PubMed ID: 25078306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal nucleic acid donor screening revealed epidemiological features of hepatitis E and prevented transfusion-transmitted infection in Japan.
    Tanaka A; Matsubayashi K; Odajima T; Sakata H; Iida J; Kai K; Goto N; Satake M
    Transfusion; 2024 Feb; 64(2):335-347. PubMed ID: 38152964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors.
    Roth NJ; Schäfer W; Alexander R; Elliott K; Elliott-Browne W; Knowles J; Wenzel JJ; Simon TL
    Transfusion; 2017 Dec; 57(12):2958-2964. PubMed ID: 28833188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.
    Hoad VC; Seed CR; Fryk JJ; Harley R; Flower RLP; Hogema BM; Kiely P; Faddy HM
    Vox Sang; 2017 Oct; 112(7):614-621. PubMed ID: 28833229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016-2020.
    Harvala H; Reynolds C; Brailsford S; Davison K
    Emerg Infect Dis; 2022 Sep; 28(9):1805-1813. PubMed ID: 35997399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in hepatitis E virus infection: Analyses of the long-term screening of blood donors in Hokkaido, Japan, 2005-2019.
    Sakata H; Matsubayashi K; Iida J; Nakauchi K; Kishimoto S; Sato S; Ikuta K; Satake M; Kino S
    Transfusion; 2021 Dec; 61(12):3390-3401. PubMed ID: 34632593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis E virus: Blood transfusion implications].
    Gallian P; Piquet Y; Assal A; Djoudi R; Chiaroni J; Izopet J; Tiberghien P
    Transfus Clin Biol; 2014 Nov; 21(4-5):173-7. PubMed ID: 25267201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis E virus infections in German blood donors: results of 8 years of screening, 2015 to 2022.
    Plümers R; Dreier J; Knabbe C; Gömer A; Steinmann E; Todt D; Vollmer T
    Euro Surveill; 2024 Jun; 29(24):. PubMed ID: 38873797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-transmission of hepatitis E virus through red blood cell transfusion but not through platelet concentrates: A case report from Spain.
    Ojea AM; Seco C; Mata P; Muñoz MDC; Álvarez Argüelles ME; Rodríguez-Frías F; Quer Sivila J; Rando Segura A; García-Gala JM; Rodriguez M
    Transfusion; 2023 Sep; 63(9):1767-1772. PubMed ID: 37593971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E virus infection in the Irish blood donor population.
    O'Riordan J; Boland F; Williams P; Donnellan J; Hogema BM; Ijaz S; Murphy WG
    Transfusion; 2016 Nov; 56(11):2868-2876. PubMed ID: 27522065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France.
    Pillonel J; Maugard C; Sommen C; Figoni J; Pierre C; LeCam S; Richard P; Morel P; Gallian P; Laperche S
    Vox Sang; 2022 Dec; 117(12):1411-1414. PubMed ID: 36394899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low transfusion transmission of hepatitis E among 25,637 single-donation, nucleic acid-tested blood donors.
    Harritshøj LH; Holm DK; Saekmose SG; Jensen BA; Hogema BM; Fischer TK; Midgley SE; Krog JS; Erikstrup C; Ullum H
    Transfusion; 2016 Sep; 56(9):2225-32. PubMed ID: 27385646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
    Weusten JJ; van Drimmelen HA; Lelie PN
    Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.